Yee Lu Tham

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report
    Yee Lu Tham
    Breast Care Center, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Breast Cancer 7:164-6. 2006
  2. ncbi The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause
    Yee Lu Tham
    Breast Care Center, Baylor College of Medicine, and The Methodist Hospital, Houston, Texas, 77030, USA
    J Support Oncol 4:295-8, 304. 2006
  3. ncbi The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane
    Yee Lu Tham
    Breast Care Center, The Methodist Hospital and Baylor College of Medicine, Houston, Texas, USA
    Am J Clin Oncol 30:126-32. 2007
  4. ncbi Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients
    Jenny C Chang
    Breast Center, Department of Medicine, Baylor College of Medicine, 1 Baylor Plaza, MS 600, Houston, TX 77030, USA
    J Clin Oncol 23:1169-77. 2005
  5. ncbi Primary breast cancer phenotypes associated with propensity for central nervous system metastases
    Yee Lu Tham
    Breast Care Center, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
    Cancer 107:696-704. 2006
  6. ncbi Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
    Yee-Lu Tham
    Breast Center and the Department of Medicine, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
    Breast Cancer Res Treat 94:279-84. 2005
  7. ncbi Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer
    Yee-Lu Tham
    Breast Center at Baylor College of Medicine, Houston, TX 77030, USA
    Breast Cancer Res Treat 74:131-4. 2002

Detail Information

Publications7

  1. ncbi Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report
    Yee Lu Tham
    Breast Care Center, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Breast Cancer 7:164-6. 2006
    ..The significance of persistent circulating tumor cells in the CNS in patients without evidence of disease is unclear but should be investigated further...
  2. ncbi The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause
    Yee Lu Tham
    Breast Care Center, Baylor College of Medicine, and The Methodist Hospital, Houston, Texas, 77030, USA
    J Support Oncol 4:295-8, 304. 2006
    ..05). More emphasis must be given to educating breast cancer survivors with chemotherapy-induced menopause about bone health and its maintenance. Approved therapies to prevent osteoporosis probably are underused in this population...
  3. ncbi The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane
    Yee Lu Tham
    Breast Care Center, The Methodist Hospital and Baylor College of Medicine, Houston, Texas, USA
    Am J Clin Oncol 30:126-32. 2007
    ..The incidence of chemotherapy-induced amenorrhea (CIA) resulting from doxorubicin and cyclophosphamide (AC) followed by a taxane (T) is poorly characterized...
  4. ncbi Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients
    Jenny C Chang
    Breast Center, Department of Medicine, Baylor College of Medicine, 1 Baylor Plaza, MS 600, Houston, TX 77030, USA
    J Clin Oncol 23:1169-77. 2005
    ..Chemotherapy for operable breast cancer decreases the risk of death. Docetaxel is one of the most active agents in breast cancer, but resistance or incomplete response is frequent...
  5. ncbi Primary breast cancer phenotypes associated with propensity for central nervous system metastases
    Yee Lu Tham
    Breast Care Center, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
    Cancer 107:696-704. 2006
    ..It is unclear whether specific tumor biological properties or the use of systemic therapies influence this risk...
  6. ncbi Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
    Yee-Lu Tham
    Breast Center and the Department of Medicine, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
    Breast Cancer Res Treat 94:279-84. 2005
    ..Docetaxel acts therapeutically by inducing apoptosis and this can be used as a marker of response...
  7. ncbi Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer
    Yee-Lu Tham
    Breast Center at Baylor College of Medicine, Houston, TX 77030, USA
    Breast Cancer Res Treat 74:131-4. 2002
    ..We describe three cases, of both reversible and irreversible cardiomyopathy, associated with the use of this novel and effective agent in HER-2 overexpressing breast cancer...